Clinical Trials Logo

Seasonal Allergic Rhinitis clinical trials

View clinical trials related to Seasonal Allergic Rhinitis.

Filter by:

NCT ID: NCT00539006 Completed - Clinical trials for Seasonal Allergic Rhinitis

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of this replicate study to FFU105927 is to provide data on subject preference of FFNS as compared with FPNS.

NCT ID: NCT00519636 Completed - Clinical trials for Seasonal Allergic Rhinitis

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Start date: August 2007
Phase: Phase 4
Study type: Interventional

The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.

NCT ID: NCT00517946 Completed - Clinical trials for Seasonal Allergic Rhinitis

A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage.

Start date: March 2007
Phase: N/A
Study type: Observational

The purpose of this study is to establish whether MRI scanning is a sensitive measure of the effects of existing drug treatments on nasal dimensions following challenge with intranasal allergen in subjects with hayfever. If successful this technique could be applied to increase confidence for internal decision making and ultimately may be used to assess how effective a new drug treatment is.

NCT ID: NCT00504933 Completed - Clinical trials for Seasonal Allergic Rhinitis

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The objective of the study is to evaluate the efficacy and tolerability of Bilastine 20 mg, compared to Cetirizine and placebo for the treatment of seasonal allergic rhinitis.

NCT ID: NCT00491504 Completed - Clinical trials for Seasonal Allergic Rhinitis

This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)

Start date: February 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate how well mometasone furoate nasal spray (MFNS) works to relieve SAR symptoms compared to Placebo when symptoms are induced in a chamber setting. Evaluation will be based on subjects self-assessed nose symptoms. Other areas the study will evaluate are: 1) changes in eye symptoms (ocular symptom severity score) after dosing 2) how long MFNS works in relieving the nose (nasal) and eye (ocular) symptoms after 7 daily doses, 3) measurements of nose (nasal) blockage (obstruction), and 4) measurements of the subject's opinion of the study drugs by asking different questions. This study is could last up to 53 days for some subjects.

NCT ID: NCT00483353 Completed - Clinical trials for Seasonal Allergic Rhinitis

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

Start date: July 2007
Phase: Phase 1
Study type: Interventional

The current study will investigate nasal inflammatory markers obtained by filter paper collection techniques, in subjects with allergic rhinitis, determining the most appropriate time points and handling conditions, prior to running a larger study with subjects with allergic rhinitis.

NCT ID: NCT00473915 Completed - Clinical trials for Seasonal Allergic Rhinitis

Intranasal Steroids and the Nasal Ocular Response

Start date: April 2007
Phase: Phase 4
Study type: Interventional

Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.

NCT ID: NCT00468312 Completed - Clinical trials for Seasonal Allergic Rhinitis

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study is designed to assess the effectiveness of mometasone furoate nasal spray (MFNS) once daily compared with placebo in subjects with seasonal allergic rhinitis (SAR) in reducing the total symptom score.

NCT ID: NCT00460538 Completed - Clinical trials for Seasonal Allergic Rhinitis

Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms

Start date: April 2007
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.

NCT ID: NCT00453063 Completed - Clinical trials for Seasonal Allergic Rhinitis

Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study is designed to assess the effectiveness of mometasone furoate nasal spay (MFNS) once daily (QD) compared with placebo in subjects with seasonal allergic rhinitis (SAR) in reducing the total nasal symptom score and the total ocular symptom score.